DFine's STAR Spinal Tumor Ablation System To Hit U.S. Market In Q4
This article was originally published in The Gray Sheet
Executive Summary
DFine plans to begin a gradual commercial launch late this year of its STAR system, designed to help cancer patients suffering from painful metastases in the spine.